Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
20.44
-0.07 (-0.32%)
Nov 21, 2024, 12:42 PM EST - Market open
Pharvaris Employees
Pharvaris had 82 employees as of December 31, 2023. The number of employees increased by 17 or 26.15% compared to the previous year.
Employees
82
Change (1Y)
17
Growth (1Y)
26.15%
Revenue / Employee
n/a
Profits / Employee
-$1,798,233
Market Cap
1.10B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 82 | 17 | 26.15% |
Dec 31, 2022 | 65 | 31 | 91.18% |
Dec 31, 2021 | 34 | 20 | 142.86% |
Dec 31, 2020 | 14 | 11 | 366.67% |
Dec 31, 2019 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Aveanna Healthcare Holdings | 33,500 |
OPKO Health | 3,930 |
Artivion | 1,500 |
Phreesia | 1,438 |
Maravai LifeSciences Holdings | 650 |
CareDx | 643 |
Progyny | 566 |
Aurinia Pharmaceuticals | 300 |
PHVS News
- 7 days ago - Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 9 days ago - Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference - GlobeNewsWire
- 5 weeks ago - Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings - GlobeNewsWire
- 5 weeks ago - Pharvaris to Host Virtual Investor Event on October 23, 2024 - GlobeNewsWire
- 7 weeks ago - Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop - GlobeNewsWire
- 2 months ago - Pharvaris Provides Business Update and Expands Development Program for Deucrictibant - GlobeNewsWire
- 2 months ago - Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 - GlobeNewsWire
- 2 months ago - Pharvaris Presents Data at the Bradykinin Symposium 2024 - GlobeNewsWire